Retatrutide in Singapore: Availability, Safety, and What Patients Should Know

Interest in advanced weight management medications has grown rapidly in recent years, particularly in Singapore where obesity and metabolic conditions increasingly affect long-term health outcomes. One name that is increasingly appearing in online searches is retatrutide – often associated with headlines about dramatic weight loss and “next-generation” therapies.

Searches for “retatrutide Singapore” commonly reflect a few key questions: Is retatrutide available locally? Is it safe? Is it approved by Singapore’s Health Sciences Authority (HSA)? And how does it compare to existing treatments?

This article, written by the clinical team at Sire Men’s Health Clinic, provides a clear overview of retratrutide, with a focus on what Singapore patients should know today.

What is Retatrutide, and Why is it Gaining Attention?

Retatrutide is an investigational medication currently under international clinical development for the treatment of obesity and metabolic disease. It has not yet been approved for routine medical use in any country, including Singapore.

What makes retatrutide notable is its triple-agonist mechanism, meaning it acts on three hormone receptors involved in appetite regulation and metabolism:

• GLP-1 (glucagon-like peptide-1)
• GIP (glucose-dependent insulinotropic polypeptide)
• Glucagon receptor

This multi-pathway approach is different from earlier weight loss injections like semaglutide or tirzepatide that target only one or two receptors, respectively. As a result, retatrutide has attracted attention in medical research circles for its potential to influence both appetite control and energy expenditure.

How Does Retatrutide Work in the Body?

Retatrutide is designed to influence metabolic regulation through complementary hormonal pathways.

Effects on Appetite and Satiety

Activation of GLP-1 receptors helps signal fullness to the brain, reducing hunger and food intake. This mechanism is already well established in currently approved GLP 1 medications.

Effects on Insulin and Metabolism

GIP receptor activity may improve insulin sensitivity and how the body processes nutrients after meals.

Effects on Energy Use

Unlike standard GLP 1 medications, retatrutide also stimulates the glucagon receptor. This may increase energy expenditure and fat utilisation, which researchers believe could contribute to greater overall weight reduction.

It is important to note that these mechanisms are still being studied, and their long-term effects require further clinical validation.

Is Retatrutide Approved or Available in Singapore?

No. Retatrutide is not approved by Singapore’s Health Sciences Authority (HSA) and is not legally available for prescription or sale in Singapore.

At present:

• Retatrutide remains an investigational drug
• It is restricted to regulated clinical trials
• Singapore doctors cannot prescribe or dispense retatrutide outside of approved research settings

Any product marketed as “retatrutide” for sale to consumers in Singapore is not legitimate and may pose serious health risks.

Why Retatrutide Cannot Be Prescribed in Singapore Yet

Singapore has one of the most stringent medication regulatory frameworks globally. Before approval, the HSA requires:

1. Robust Phase 3 clinical trial data
2. Clear evidence of long-term safety
3. Demonstrated benefit that outweighs potential risks
4. Manufacturing quality assurance

While retatrutide has shown promising early trial results, it has not yet completed the full regulatory review process required for patient use in Singapore.

What Have Clinical Trials Shown So Far?

Weight Loss Observed in Studies

In international Phase 2 studies conducted by Eli Lilly, participants receiving retatrutide experienced substantial average weight loss, in some cases exceeding 20% of baseline body weight over approximately one year.

These results published in the New England Journal of Medicine have understandably generated interest, particularly among individuals who have struggled with obesity despite lifestyle changes or existing weight loss medication.

Metabolic Improvements

Beyond weight reduction, studies have also reported improvements in:

• Blood glucose control
• Insulin sensitivity
• Lipid profiles
• Blood pressure

However, these findings remain preliminary and subject to further confirmation in larger Phase 3 trials.

What Side Effects Have Been Reported in Trials? 

As with other incretin-based therapies, retatrutide has been associated with side effects, most commonly involving the gastrointestinal system.

Reported side effects include:

• Nausea
• Diarrhoea
• Vomiting
• Reduced appetite
• Abdominal discomfort

In some trials, a proportion of participants discontinued treatment due to side effects. This underscores why long-term safety evaluation is essential before widespread use.

How is Retatrutide Different from Semaglutide or Tirzepatide?

Patients searching for retatrutide Singapore often want to understand how it compares to existing treatments.

Semaglutide (e.g. Ozempic, Wegovy)

• Acts on GLP-1 receptors (GLP 1 RA)
• Approved in Singapore
• Well-established safety profile with long-term data

Tirzepatide (e.g. Mounjaro)

• Acts on GLP-1 and GIP receptors (dual agonist)
• Approved in Singapore
• Produces greater average weight loss than older GLP-1 therapies

Retatrutide

• Acts on GLP-1, GIP, and glucagon receptors
• Investigational only
• Not approved in Singapore
• Long-term safety still under evaluation

While retatrutide may eventually offer an additional option, it is not a substitute for approved treatments available today.

Are Online or Overseas Retatrutide Products Safe?

No. Products claiming to be retatrutide sold online, through social media, or via overseas suppliers are unregulated and potentially dangerous.

Risks include:

• Incorrect or unknown ingredients
• Unsafe dosing
• Contamination or sterility issues
• Absence of medical monitoring

Singapore’s HSA has repeatedly warned against the use of unlicensed medicines, particularly injectable weight loss medication.

What Weight Management Treatments Are Currently Approved in Singapore?

While retatrutide is not available, several evidence-based options are legally approved and prescribed under medical supervision in Singapore.

These include:

• GLP-1 receptor agonist (GLP 1 RA) injections
• Dual agonist therapies
• Oral metabolic medications
• Structured lifestyle and nutritional programmes

At Sire Men’ Health Clinic, treatment decisions are based on individual health profiles, not trends or unapproved therapies. Weight management is approached as a medical condition, not a cosmetic issue.

Who May Benefit from Medical Weight Management?

Medically supervised weight management may be appropriate for individuals who:

• Have obesity or overweight with metabolic risk factors
• Have not achieved results with lifestyle changes alone
• Have conditions such as insulin resistance, hypertension, or dyslipidaemia

A proper assessment includes blood tests, medical history, and an evaluation of long-term health risks.

When Might Retatrutide Become Available in Singapore?

There is currently no confirmed timeline for retatrutide approval in Singapore.

Regulatory approval depends on:

• Completion of Phase 3 trials
• Regulatory submissions
• HSA safety and efficacy review

Even if approved internationally, Singapore approval is not automatic and follows its own regulatory process.

What Should Patients Do If They Are Interested in New Weight Loss Treatments?

Patients interested in emerging therapies should:

1. Consult a licensed Singapore doctor
2. Rely on medication from HSA-regulated sources
3. Avoid unverified online products
4. Focus on sustainable, supervised treatment plans

At Sire Men’s Health Clinic, patient safety and evidence-based care are central to all clinical decisions.

Key Takeaways About Retatrutide in Singapore

• Retatrutide is an investigational triple-agonist medication
• It is not approved or available in Singapore
• Online or overseas products claiming to be retatrutide are unsafe
• Approved medical weight management options already exist
• Medical supervision and regulatory compliance are essential

Final Thoughts

The growing interest in retatrutide Singapore reflects a broader shift toward medical approaches to weight and metabolic health. While research into new therapies is encouraging, patient safety and regulatory oversight must always come first. 

Until retatrutide completes clinical trials and receives HSA regulatory approval, Singapore patients should rely on proven, approved treatments guided by qualified medical professionals.

For accurate information, personalised assessment, and safe care, consult a licensed medical clinic with experience in men’s metabolic and weight health – such as Sire Men’s Health Clinic.